Molecular Team Leader
I joined ANGLE to head up the UK Molecular Group and it’s laboratories, exploring the diagnostic capability of CTC’s harvested from a simple blood draw from ANGLE’s Parsortix instrument.I project managed and delivered on several key Molecular work packages and collaborations, as well as shaped the company's IVD Molecular strategy, exploring the utility of various technologies such as Single Cell Sequencing.During my time here, I was also a key contributor to the successful FDA PMA approval of the Parsortix instrument itself, under CFR 21 Part 820.